Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    September 2024
  1. THORAT MA, Cuzick J, Chan AT
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15497.
    PubMed    


  2. PETRELLI F, Ghidini A
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15491.
    PubMed    


  3. LI C, He J, Liang W
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15488.
    PubMed    


  4. SUN R, Wei LJ
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15494.
    PubMed    


  5. CHEN WY, Ballman KV, Holmes MD
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer-Reply.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15500.
    PubMed    


  6. RYAN CE, Fasaye GA, Gallanis AF, Gamble LA, et al
    Germline CDH1 Variants and Lifetime Cancer Risk.
    JAMA. 2024;332:722-729.
    PubMed     Abstract available


    August 2024
  7. HARRIS E
    More Data About Risks, Benefits Might Change Breast Cancer Screening Choice.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13777.
    PubMed    


    July 2024
  8. LEON-FERRE RA, Salgado R, Jonas SF
    Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer-Reply.
    JAMA. 2024 Jul 3. doi: 10.1001/jama.2024.10483.
    PubMed    


  9. TU H, Zhang Y, You Z
    Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer.
    JAMA. 2024 Jul 3. doi: 10.1001/jama.2024.10480.
    PubMed    


    June 2024
  10. RUBIN R
    Despite New Recommendations, the Debate Over Mammography Guidelines Continues.
    JAMA. 2024;331:1877-1879.
    PubMed    


    May 2024
  11. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
    The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    JAMA. 2024;331:1748-1760.
    PubMed     Abstract available


  12. MANDELBLATT JS, Mainor C, Hudson BI
    The Aspirin Conundrum-Navigating Negative Results, Age, Aging Dynamics, and Equity.
    JAMA. 2024;331:1709-1711.
    PubMed    


  13. HARRIS E
    Young Patients Without Genetic Risk Have Low Chance of Second Breast Cancer.
    JAMA. 2024 May 3. doi: 10.1001/jama.2024.6734.
    PubMed    


    April 2024
  14. TRENTHAM-DIETZ A, Chapman CH, Jayasekera J, Lowry KP, et al
    Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2023.24766.
    PubMed     Abstract available


  15. NICHOLSON WK, Silverstein M, Wong JB, Barry MJ, et al
    Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.5534.
    PubMed     Abstract available


  16. HENDERSON JT, Webber EM, Weyrich MS, Miller M, et al
    Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2023.25844.
    PubMed     Abstract available



  17. Screening for Breast Cancer.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.5535.
    PubMed    


  18. ELMORE JG, Lee CI
    Toward More Equitable Breast Cancer Outcomes.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.6052.
    PubMed    


  19. CHEN WY, Ballman KV, Partridge AH, Hahn OM, et al
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.
    JAMA. 2024 Apr 29:e244840. doi: 10.1001/jama.2024.4840.
    PubMed     Abstract available


  20. CASWELL-JIN JL, Kurian AW, Plevritis SK
    US Breast Cancer Mortality-Reply.
    JAMA. 2024 Apr 25. doi: 10.1001/jama.2024.5482.
    PubMed    


  21. JATOI I
    US Breast Cancer Mortality.
    JAMA. 2024 Apr 25. doi: 10.1001/jama.2024.5479.
    PubMed    


  22. NAROD SA
    Breast Cancer and Pregnancy in Young BRCA Carriers.
    JAMA. 2024;331:1233-1234.
    PubMed    


  23. BLONDEAUX E, Partridge AH, Lambertini M
    Breast Cancer and Pregnancy in Young BRCA Carriers-Reply.
    JAMA. 2024;331:1234.
    PubMed    


  24. LEON-FERRE RA, Jonas SF, Salgado R, Loi S, et al
    Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
    JAMA. 2024;331:1135-1144.
    PubMed     Abstract available


    January 2024
  25. WHEELER SB, Rocque G, Basch E
    Benefits of Breast Cancer Screening and Treatment on Mortality.
    JAMA. 2024;331:199-200.
    PubMed    


  26. CASWELL-JIN JL, Sun LP, Munoz D, Lu Y, et al
    Analysis of Breast Cancer Mortality in the US-1975 to 2019.
    JAMA. 2024;331:233-241.
    PubMed     Abstract available


    December 2023
  27. LAMBERTINI M, Blondeaux E, Agostinetto E, Hamy AS, et al
    Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
    JAMA. 2023 Dec 7. doi: 10.1001/jama.2023.25463.
    PubMed     Abstract available


    September 2023
  28. HARRIS E
    Air Pollution Tied With Increased Chance of Breast Cancer.
    JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18745.
    PubMed    


    August 2023
  29. HARRIS E
    Breast Cancer Overdiagnosis Common Among Older Women.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.13935.
    PubMed    


    July 2023
  30. KURIAN AW, Abrahamse P, Furgal A, Ward KC, et al
    Germline Genetic Testing After Cancer Diagnosis.
    JAMA. 2023;330:43-51.
    PubMed     Abstract available


    June 2023
  31. HARRIS E
    Most Women With Early Invasive Breast Cancer Survive.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10741.
    PubMed    


    May 2023
  32. HARRIS E
    Pausing Endocrine Therapy for Pregnancy After Breast Cancer Found Safe.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8659.
    PubMed    


    March 2023
  33. HARRIS E
    Study: Breast Radiotherapy Does Not Improve Survival in Older Patients.
    JAMA. 2023;329:874.
    PubMed    


    January 2023
  34. KRESSIN NR, Slanetz PJ, Gunn CM
    Ensuring Clarity and Understandability of the FDA's Breast Density Notifications.
    JAMA. 2023;329:121-122.
    PubMed    


    October 2022
  35. SLOMSKI A
    Fertility Preservation After Breast Cancer Diagnosis.
    JAMA. 2022;328:1289.
    PubMed    


    September 2022
  36. LARKIN HD
    First Therapy Targeting ERBB2-Low Breast Cancer Approved.
    JAMA. 2022;328:819.
    PubMed    


    July 2022
  37. SWAIN M, Jeudy M
    Breast Masses in Biological Females.
    JAMA. 2022;328:294-295.
    PubMed    


    June 2022
  38. KERLIKOWSKE K, Su YR, Sprague BL, Tosteson ANA, et al
    Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
    JAMA. 2022;327:2220-2230.
    PubMed     Abstract available


  39. FRIEDEWALD SM, Grimm LJ
    Digital Breast Tomosynthesis and Detection of Interval Invasive and Advanced Breast Cancers.
    JAMA. 2022;327:2198-2200.
    PubMed    


  40. SLOMSKI A
    Greater Well-being After Breast Conservation Surgery vs Mastectomy.
    JAMA. 2022;327:2066.
    PubMed    


    May 2022
  41. GOODWIN PJ, Chen BE, Gelmon KA, Whelan TJ, et al
    Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
    JAMA. 2022;327:1963-1973.
    PubMed     Abstract available


    April 2022
  42. SLOMSKI A
    Exercise Improves Shoulder Function After Breast Cancer Surgery.
    JAMA. 2022;327:1539.
    PubMed    


  43. SURAN M
    Stagnant US Mammography Rates and the Influence of COVID-19.
    JAMA. 2022 Apr 20. pii: 2791573. doi: 10.1001/jama.2022.4295.
    PubMed    


    January 2022
  44. HAHN EE, Munoz-Plaza CE, Pounds D, Lyons LJ, et al
    Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2022;327:41-49.
    PubMed     Abstract available


    December 2021
  45. LAM DL, Flanagan MR
    Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
    JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
    PubMed    


    October 2021
  46. VAN DYK K, Ganz PA
    Cancer-Related Cognitive Impairment in Patients With a History of Breast Cancer.
    JAMA. 2021 Oct 15. pii: 2785382. doi: 10.1001/jama.2021.13309.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.